ELDN Eledon Pharmaceuticals, Inc.
Healthcare$3.89+0.00%ClosedMarket Cap: $233.2M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
4.35
P/S
0.00
EV/EBITDA
-2.63
DCF Value
$0.24
FCF Yield
-29.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-96.8%
ROA
-53.3%
ROIC
-64.7%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | NaN% | $-21.2M | $-39.0M | $— | — |
| Q4 null | $0.00 | NaN% | $-21.5M | $-10.4M | $— | — |
| FY null | $0.00 | NaN% | $-83.3M | $-45.6M | $— | — |
| Q3 null | $0.00 | NaN% | $-19.1M | $-17.5M | $— | — |
| Q2 null | $0.00 | NaN% | $-24.7M | $-11.2M | $— | — |
| Q1 null | $0.00 | NaN% | $-18.0M | $-6.5M | $— | — |
| Q4 null | $0.00 | NaN% | $-24.7M | $-44.6M | $— | — |
| FY null | $0.00 | NaN% | $-70.6M | $-36.2M | $— | — |
| Q3 null | $0.00 | NaN% | $-20.5M | $77.0M | $— | — |
| Q2 null | $0.00 | NaN% | $-14.5M | $-44.9M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-10.9M | $-23.6M | $— | — |
| Q4 2023 | $0.00 | -Infinity% | $-10.3M | $-85.8M | $-3.55 | — |